HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
Gilead and Arcus Biosciences established 10-year partnership to co-develop and co-commercialize next-generation cancer immunotherapies
On May 27, 2020, Gilead Sciences and Arcus Biosciences announced that the companies had entered into a 10-year…
AIM ImmunoTech announced FDA authorization for first human ampligen trial in COVID-19 patients with cancer
On May 14, 2020, AIM ImmunoTech announced the FDA authorized the first human trial assessing the safety and…
Cancer patients face high mortality from COVID-19
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Phase 3 trial of Libtayo (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival
On Apr. 27, 2020, Regeneron and Sanofi announced the primary endpoint of overall survival was met in a…
CTI Biopharma announced initiation of phase 3 PRE-VENT study evaluating Pacritinib in hospitalized patients with severe COVID-19
On Apr. 27, 2020, CTI BioPharma announced initiation of PRE-VENT, a Phase 3 study evaluating pacritinib in hospitalized…
AstraZeneca initiated CALAVI clinical trial with Calquence against COVID-19
On Apr. 14, 2020, AstraZeneca initiated a randomised, global clinical trial to assess the potential of Calquence (acalabrutinib)…
MediciNova announced plans to initiate a clinical trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
FDA approved BRAFTOVIﾮ (Encorafenib) in combination with Cetuximab for treatment of BRAFV600E-mutant metastatic colorectal cancer
On Apr. 9, 2020, Pfizer announced that the FDA had approved BRAFTOVIﾮ (encorafenib) in combination with cetuximab (marketed…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
Roswell Park’s Dr. Pawel Kalinski lead $145 million NCI-funded immunotherapy effort
On Mar. 31, 2020, a team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center…
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
The Priestley Medal was awarded to JoAnne Stubbe
On Mar. 23 2020, The Priestley Medal was awarded to JoAnne Stubbe by the American Chemical Society “to…
Todos Medical announced Coronavirus Nucleic Acid Buccal Testing Kit distribution agreement with 3D BioMed
On Mar. 17, 2020, Todos Medical announced a non-exclusive distribution agreement with 3D Biomedicine Science & Technology, a…
UMN Institute scientist links ancient virus to cancer risk
On Mar. 16, 2020, the Hormel Institute, University of Minnesota announced published research concerning remnants of ancient viruses…
Testing with combined biopsy method improves prostate cancer diagnosis in NCI study
On Mar. 4, 2020, a method of testing for prostate cancer developed at the National Cancer Institute (NCI)…
Gilead acquired Forty Seven for $49 billion in cash
On Mar. 2, 2020,Gilead Sciences announced it had acquired Forty Seven Inc. for $95.50 per share in cash…
Tim and Mary Boyle gave $10 million to OHSU for joint center for biomedical data science
On Feb. 20, 2020, Tim Boyle, CEO of Columbia Sportswear, and his wife, Mary, made a $10 million…
The CPRIT awarded 55 new grants totaling over $78 million
On Feb. 19, 2020, the Cancer Prevention & Research Institute of Texas (CPRIT) announced it had awarded 55…
New, detailed molecular roadmap boosted fight against endometrial cancer
On Feb. 13, 2020, a study published in Cell provided an unprecedented look at the dozens of molecular…
The Pan-cancer analysis of whole genomes was published in Nature
On Feb. 5, 2020, The Pan-cancer analysis of whole genomes was published in Nature. The flagship paper of…
International collaboration generated most complete cancer genome map to date
On Feb. 5, 2020, an international team announced that it had completed the most comprehensive study of whole…
The Cancer Prevention and Research Institute of Texas announced it had recruited its 200th CPRIT scholar
On Jan. 27, 2020, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had recruited its…
Karmanos Cancer Institute was awarded the President’s Trophy for second year in a row by McLaren Health Care
On Jan. 16, 2020, the Barbara Ann Karmanos Cancer Institute received the President’s Trophy for the second year…
Thomas J. Lynch Jr became the sixth president of the Fred Hutchinson Cancer Research Center
On Jan. 7, 2020, the Fred Hutchinson Cancer Research Center announced Dr. Thomas J. Lynch Jr. as the…
Karmanos Cancer Institute received the 2020 Women’s Choice Award
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
The Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy project
On Dec. 18, 2019, the Jackson Laboratory received $2.5 million from The Mark Foundation for breakthrough cancer immunotherapy…